Vimarsana
Biggest News Aggregation in the World

Pharma Securityholder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Securityholder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Securityholder Today - Breaking & Trending Today

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement - Vimarsana News

FSD Pharma Inc. Obtains Final Order for Plan of Arrangement

TORONTO, ON / ACCESSWIRE / November 27, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis - Vimarsana News

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis

BioPharma

FSD Pharma : ARRANGEMENT AGREEMENT - Form 6-K -November 07, 2023 at 06:06 am EST - Vimarsana News

FSD Pharma : ARRANGEMENT AGREEMENT - Form 6-K -November 07, 2023 at 06:06 am EST

ARRANGEMENTAGREEMENT THIS ARRANGEMENT AGREEMENT is made as of the 4th day of October, 2023. BETWEEN: FSD PHARMA INC., a...

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders ... - Vimarsana News

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders ...

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders ...

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis - Vimarsana News

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis

FSD Pharma Inc. (FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to announce that the company, in the upcoming weeks...